Megan Melody, Clinical Director of Cellular Therapy at Tampa General Hospital, shared a post on LinkedIn:
“Truly grateful to DAVA Oncology for the opportunity to present my research on CAR T-Cell Therapy and Hodgkin Lymphoma at the 5th Translational Summit on Hematologic Malignancies.
An inspiring meeting in a beautiful setting, surrounded by exceptional colleagues.
Thank you for the invitation and the meaningful exchange of ideas.”

Other articles featuring Dr. Melody on OncoDaily.